SIME Diagnostics

📍 London, United Kingdom👥 33 employees💰 Last funded Oct 2013
Biotechnology Research🌐 simedx.com
Website LinkedIn
SIME is a clinical AI company applying medical excellence, proprietary AI and data ingenuity to deliver rapid respiratory intensive care diagnostics for acute unmet needs. Our clinically proven technology enables early intervention in life-threatening diseases - improving outcomes and reducing costs.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investor
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in SIME Diagnostics?
SIME Diagnostics has 1 investor on record on gritt.io.
When did SIME Diagnostics last raise funding?
The most recent investment in SIME Diagnostics recorded on gritt.io was in October 2013.
What industry is SIME Diagnostics in?
SIME Diagnostics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is SIME Diagnostics based?
SIME Diagnostics is headquartered in London, United Kingdom.